No valuation for Thryv Therapeutics is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($16.5M) and the funding record below are the closest available signals.
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for Thryv Therapeutics
- ·The full record, as it builds
Funding history
No funding rounds for Thryv Therapeutics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
How Thryv Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Thryv Therapeutics, we compose those signals into the PA Mark — a weighted composite of 1 recent pricing inputs, decayed by age and reset on new rounds. The implied valuation multiplies the mark by shares outstanding. Full methodology →
Frequently asked
- How much has Thryv Therapeutics raised?
- Thryv Therapeutics has raised $16.5M in total funding across its recorded rounds.